Home > Funding & Research > Research > Who and what we fund > Research topic > Immunotherapy

• Who and what we fund

  • Institutions

  • Locations

  • Cancer type

  • Research topic

    • Immunotherapy

• How we deliver our research

• Drug development

• Research strategy

Our research into immunotherapy

Some of our researchers are working on a new type of cancer treatment called ‘immunotherapy’. This exciting approach aims to harness the specificity and power of the body’s immune system to target and destroy cancer cells.

Scientists in this field are working on a variety of ways to boost the immune system’s anti-tumour responses. These range from monoclonal antibodies to cancer vaccines that are being designed to treat a range of different cancer types. Some of these immunotherapies are being tested in early-phase clinical trials.

Other research teams are supporting these efforts by working to understand in greater detail how the body’s immune system fights infection. This knowledge will help to improve the design of new immunotherapies in the future.

You can find out more about immunotherapy in our Learn about cancer section, or visit MyProjects to donate directly to our immunotherapy research in London and Southampton.

Below are some highlights of our immunotherapy research portfolio.

Updated: 17 September 2009

• Terms & Conditions

• Privacy

• Cookies

• Accessibility

• Contact us

• Site map

Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666) and the Isle of Man (1103).
A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F).
Registered address: Angel Building, 407 St John Street, London EC1V 4AD.